Moreover, it has been reported previously that increased DEPTOR rendered cancer cells more resistant to chemotherapeutic drugs, which could be restored by AKT inactivation [45, 46], and DEPTOR overexpression correlates with poor prognosis of hepatocellular carcinoma and differentiated thyroid carcinoma patients [23, 24]. This evidence concerns the gene DEPTOR and differentiated thyroid carcinoma.